Current role
Kathleen Richton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kathleen Richton
enGene Therapeutics Inc. reported in an 8-K filed June 15, 2026 that Kathleen Richton was appointed Senior Vice President, Finance, effective July 16, 2026.
“On June 14, 2026, the Board appointed Kathleen Richton as Senior Vice President, Finance of the Company, with her appointment to become effective on or about July 16, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
enGene Therapeutics Inc. (ENGN)
SEC 8-K
Current2026-07-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at enGene Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.